Search

Test anxiety disorder is a group of symptoms related to stress caused by tests, exams, evaluations, and others. It is among the severe psychological problems in exams. Long-term test anxiety is likely to cause tension, fear, irritability, depression, and other negative emotions, and it disturbs working memory, attention, and other cognitive abilities and even leads to suicidal ideation. In order to standardize the clinical diagnosis and treatment of test anxiety disorder, under the organization of the Test Anxiety Disorder Collaboration of the Chinese Society of Psychosomatic Medicine, this expert consensus was formulated by 13 experts in the field of psychiatry and psychology. We collaborate and announce the expert consensus based on current research and clinical experience. We hope the consensus can provide clinicians with scientific and comprehensive guidance on test anxiety disorder, including epidemiology, etiology, clinical manifestations, evaluation, and treatment.

Background Socioeconomic development, lifestyle changes and the COVID-19 pandemic all have an impact on people's mental and physical health, which may affect the prevalence of mental disorders. Currently, there is still no sufficient epidemiological information of mental disorders in Xinjiang. Objective To investigate the prevalence and influencing factors of common mental disorders among people aged 15 and above in northern Xinjiang, then compare the data with those of their counterparts in southern Xinjiang, and summarize the overall prevalence of common mental disorders in Xinjiang, providing a scientific basis for the formulation of corresponding mental health plans. Methods From November 2021 to July 2022, a multistage, stratified, random sampling method was used to select 3 853 residents from northern Xinjiang to attend a survey. General Demographic Questionnaire, and self-assessment scales (the 12-Item General Health Questionnaire, Mood Disorder Questionnaire, Symptom Checklist-90, etc.) and other assessment scales (Hamilton Depression Inventory, Bech-Rafaelsen Mania Rating Scale, Brief Psychiatric Rating Scale, etc.) were used as survey instruments. Mental disorders were diagnosed by the ICD-10 classification of mental and behavioral disorders by two psychiatrists with at least five years' working experience, or by a chief or associate chief psychiatrist when there is an inconsistency between the diagnoses made by the two psychiatrists. Results The point prevalence rate and age-adjusted rate of common mental disorders in northern Xinjiang were 9.71% (374/3 853) and 10.07%, respectively. The point prevalence rate and age-adjusted rate of common mental disorders in the whole Xinjiang were 9.69% (750/7 736) and 9.90%, respectively. The point prevalence rates of mood disorders, anxiety disorders, schizophrenia, organic mental disorders, and mental retardation in northern Xinjiang were 4.83% (374/7 736), 3.63% (281/7 736), 0.63% (49/7 736), 0.23% (18/7 736), and 0.36% (28/7 736), respectively. Multivariate Logistic regression analysis for northern Xinjiang showed that: the risk of mood disorders in females was 1.854 times higher than that in males〔95%CI (1.325, 2.593) 〕; The risk of mood disorders increased by 5.210 times in 25-34-year-olds〔95%CI (1.348, 20.143) 〕 and 3.863 times in 35-44-year-olds 〔95%CI (1.030, 14.485) 〕 compared with that in those aged ≥65 years; The risk of mood disorders increased by 0.199 times in those with high school or technical secondary school education〔95%CI (0.078, 0.509) 〕 and 0.147 times in those with two- or three-year college and above education〔95%CI (0.056, 0.388) 〕 compared with that in illiteracies. The risk of anxiety disorder in females was 1.627 times higher than that in males〔95%CI (1.144, 2.315) 〕; The risk of anxiety disorder increased by 0.257 times in 15-24-year-olds〔95%CI (0.091, 0.729) 〕, 0.243 times in 45-54-year-olds〔95%CI (0.101, 0.583) 〕, and 0.210 times in 55-64-year-olds〔95%CI (0.067, 0.661) 〕 compared to that of those aged ≥65 years old. The risk of schizophrenia among people living in villages or towns was 4.762 times higher than that of those living in cities〔95%CI (1.705, 13.300) 〕; The risk of schizophrenia among people with high school or technical secondary school education was 0.079 times higher than that of illiteracies〔95%CI (0.015, 0.405) 〕. Conclusion The prevalence of mood disorders and anxiety disorders is high among all types of mental disorders in Xinjiang. Females, rural people, or low educated people in northern Xinjiang are more prone to various types of mental disorders.

BackgroundSchizophrenia is a common mental disease with high rates of recurrence and disability. The therapeutic effects of antipsychotic drugs monotherapy are insufficient on improving patients' ability to daily life and social functioning, with possible adverse reactions. Therefore, early, comprehensive and whole course management is necessary for the improvement of patients' symptoms, ability to daily life and social functioning, to help them back to society as soon as possible.ObjectiveTo assess the efficacy of whole course management in patients with schizophrenia.MethodsFrom January 2019 to Febuary 2020, one hundred and twenty-nine schizophrenia patients were recruited from Shihezi Oasis Hospital and divided into the study group (n=64) and control group (n=65) . Demographic data including gender, age, marital status and education level of all patients were recorded by researchers. Patients in the control group received the standard therapy. While, patients in the study group received the whole course management base on the standard therapy, and both of them were followed up for one year. Treatment efficacy in the two groups was assessed by Positive and Negative Syndrome Scale (PANSS, including positive, negative syndrome and the general psychopathological symptom score, used to assess the patient's psychiatric symptoms) , Social Functional Defect Screening Scale (SDSS, used to assess the degree of social functional defect) , and Activity of Daily Living Scale (ADL, used to assess the patient's ability of daily living) . And 8-item Morisky Medication Adherence Scale (MMAS-8, used to assess patient medication adherence) was used to assess medication compliance of discharged patients. And recurrence rates (used to evaluate clinical efficacy) were calculated in discharging patients only. All assessments were conducted before and 3, 6, 12 months after the study.ResultsThere were no significant differences between two groups in demographic factors including gender、age、marital status and education level and PANSS, ADL, SDSS, MMAS-8 scores (P>0.05) . Compared to the control group, there were lower scores of PANSS, SDSS and General Psychopathological Symptom Score at 6 and 12 month (P0.05) .ConclusionThe whole course management could effectively alleviate the severity of schizophrenic, and could improve the ability to daily life, social functioning, as well as medication adherence in patients with schizophrenia.